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Abstract Purpose: Studies into
the preferences of patients and rela-
tives regarding informed consent for
intensive care unit (ICU) research are
ongoing. We investigated the impact
of a study’s invasiveness on the
choice of who should give consent
and on the modalities of informed
consent. Methods: At ICU dis-
charge, randomized pairs of patients
and relatives were asked to answer a
questionnaire about informed consent
for research. One group received a
vignette of a noninvasive study; the
other, of an invasive study. Each
study comprised two scenarios, fea-
turing either a conscious or
unconscious patient. Multivariate
models assessed independent factors
related to their preferences. Results:
A total of 185 patients (40 %) and
125 relatives (68 %) responded. The
invasiveness of a study had no impact
on which people were chosen to give
consent. This increased the desire to
get more than one person to give
consent and decreased the acceptance
of deferred or two-step consent. Up to
31 % of both patients and relatives
chose people other than the patient
himself to give consent, even when
the patient was conscious. A range of
3 to 17 % of the respondents reported
that they would accept a waiving of
consent. Younger respondents and
individuals feeling coerced into study
participation wanted to be the deci-
sion makers. Conclusions: Study
invasiveness had no impact on
patients’ and relatives’ preferences
about who should give consent. Many
patients and relatives were reluctant
to give consent alone. Deferred and
two-step consent were less acceptable
for the invasive study. Further work
should investigate whether sharing
the burden of informed consent with a
second person facilitates participation
in ICU research.
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Introduction
Research is essential to further medical knowledge and
eventually improve patient care [1]. Informed consent—
respectful of a patient’s autonomy—is a key ethical
requirement in human research. It implies a competent
patient, complete information about the study (including
all invasive procedures) in plain language, and sufficient
time to decide upon participation.
Since revelations about scandalous human studies
carried out without subject consent [2, 3], developed
countries have enacted laws that bind the investigators [4,
5] to standards aimed at protecting patients. Application
of these laws differs depending on the nature of the
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research and the study population. Most laws recognize
vulnerable populations in need of enhanced protection,
such as patients who are incompetent or critically ill [6–
8].
Patients in intensive care units (ICU) face acute clin-
ical situations, with short therapeutic windows [9].
Sedation, pain, anxiety and fear can alter consciousness
and impede decision-making [10, 11], and the best prac-
tices for respecting patient autonomy in this context are
still being debated [12–14]. If the patient lacks compe-
tency to give consent, the Good Clinical Practice and
most national laws refer investigators to a surrogate—a
legal representative, relative, or close friend, depending
on the country [8, 11]. However, finding available sur-
rogates in emergency settings and obtaining their
informed consent for research is difficult [15, 16].
Moreover, their ability or willingness to take on such a
responsibility has not been demonstrated, a challenge in
which emotional burden plays a role [17–21]. To our
knowledge, patients’ and relatives’ preferences regarding
informed consent in ICU research have been investigated
separately [22, 23], but only once together [24]. The
present study investigated the preferences of both patients
and relatives as to who should give informed consent and
the modalities of that consent, as well as the impact of
study invasiveness. Such research is very important to the
design of future studies and to help clarify the best
approaches for improving medicine for critically ill
patients.
Methods
We screened all adult patients that were discharged alive
after ICU stays longer than 24 h between October 2006
and August 2007 (CC), and January 2008 and April 2008
(FG). Patients with cerebral impairment or psychiatric
disorders according to their ICU clinical charts, aged
below 18 years, and/or non French-speaking, were
excluded. The patient, and relative when available, were
met on wards 2–10 days after ICU discharge and asked to
fill in the questionnaire individually. The investigator
remained on hand to answer questions.
Since overly long questionnaires increase the risk of
refusal, each patient–relative pair was randomly assigned
one of two vignettes about a clinical study. Randomiza-
tion was performed without stratification, using sealed,
opaque envelopes to reduce bias (www.randomizer.org).
One vignette described a noninvasive study using
retrospective data extraction from patient charts, without
benefit or risk; the second vignette described an invasive
study consisting of a prospective, randomized controlled
trial, with a small risk and potential benefit to the patient
(see online data supplement E1).
The questionnaire was developed using the saturation
technique (see online data supplement E2 and [24]).
Participants chose among different people who might give
consent and among different modalities of informed
consent. Two scenarios were proposed: a conscious or
unconscious patient. Willingness to participate in the
study was purposely not investigated. Participants filled
out questionnaires in the hospital; a small number
returned them by prepaid envelope after discharge. When
necessary, a telephone reminder was made within
2 weeks.
Ethical issues
The protocol was approved by the Geneva University
Hospital Ethics Committee. A signed, returned question-
naire was considered as informed consent.
Statistical analysis
We used Stata Statistical Software, Release 11.0 (Stata
Corporation, College Station, TX, USA). All tests were
two-tailed and a p value of \0.05 was considered statis-
tically significant.
Two-tailed Fisher’s exact tests, unpaired t tests, v2 and
Pearson v2 tests were used, as appropriate, to compare
different respondent subgroups (all patients [not shown],
patients with relative, unaccompanied patients, and rela-
tives: definitions in Table 1) and to analyze answers
regarding consciousness and study invasiveness. We
performed agreements and Kappa tests for the concor-
dance of answers between pairs. Agreement tends to an
overestimation due to the contribution of hazard. The
Kappa assesses effects unrelated to hazard, but is impre-
cise and tends to underestimate concordance in the
presence of multiple items with an uneven distribution,
and if the most frequent response exceeds 80 % of
answers, the Kappa is unusable [25].
To identify factors independently associated with
outcomes, multivariate logistic regression models were
calculated considering all participants, with odds ratios
and 95 % confidence intervals. Potential interactions
between the different factors in all the multivariate
models were also assessed. All predictors at a 0.05 alpha
level in the univariate analysis were entered (factors: age,
feeling coerced, invasiveness, and respondent groups).
Results
Of 462 eligible patients, 185 participated (40 %). The
consort diagram (Fig. 1) summarizes the distribution of
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patients and relatives, as well as self-reported reasons for
refusal. Table 1 shows their characteristics. Patient age
and gender distributions were similar to our general
ICU population [age (mean ± SD): 64 ± 14 vs.
61 ± 18 years, male: 71 vs. 60 %, respectively]. Rela-
tives were younger and more frequently female. Seventy-
six relatives were life partners (62 %), 34 were children
(28 %), 3 were parents (2 %) and 10 were described as
’other’ (8 %). Compared to the general Swiss population,
matched by age (23 % primary, 46 % secondary and
31 % higher education), more respondents had a higher
education [26].
Table 2 summarizes participant preferences regarding
the person who should give consent, according to study
invasiveness and the patient’s state of consciousness.
Study invasiveness had no impact on patient or relative
preferences. Only the unaccompanied patient subgroup
showed a difference between invasive and noninvasive
study: more respondents wanted their family doctor to
give consent for the invasive study—even more so when
the patient was unconscious. More unaccompanied
patients than patients with relative wanted their family
doctor to give consent in the invasive study only. Sig-
nificantly more patients and relatives wanted relatives to
give consent on behalf of unconscious patients, whereas
both patients and relatives preferred the patient to give
consent if conscious. Up to 31 % of both patients and
relatives considered that somebody other than the patient
should give informed consent even when the patient was
conscious. Up to 48 % of patients and 41 % of relatives
considered that somebody other than the relative should
give informed consent when the patient was unconscious.
In such cases, the family or ICU doctors were the people
designated, by up to 37 and 11 %, respectively. Inde-
pendently of study invasiveness and the patient’s state of
consciousness, none of the patients or relatives chose a
lay representative, judge or hospital doctor outside the
ICU to give consent, and up to 17 % of patients and 10 %
of relatives considered that giving informed consent was
not necessary at all. The concordance of preferences
between patients and relatives was good, and was not
influenced by educational levels, relationship type or
previous participation in clinical studies (results not
shown).
Table 3 summarizes results regarding the desire for
more than one person to give consent and preferences
about the type of informed consent, depending on study
invasiveness and the patient’s state of consciousness.
State of consciousness made no difference and there was
no difference between subgroups. There was good con-
cordance between patients and relatives. More relatives
wanted ‘‘more than one person to give consent’’ for
conscious patients, and more patients with relative and
more relatives preferred ‘‘more than one person to give
consent’’ for unconscious patients in the invasive study
vignette than in the noninvasive study one. Again, family
or ICU doctors were often designated as the second per-
son (results not shown). Fewer unaccompanied patients
accepted deferred or two-step consent in the invasive
study.
The number of participants desiring a signature and/or
a witness did not differ according to study invasiveness or
between subgroups. Up to 37/62 (70 %) patients with a
relative and up to 44/63 (77 %) relatives desired a sig-
nature, while up to 32/63 (53 %) patients with a relative
and up to 30/62 (55 %) relatives desired the presence of a
witness (see online data supplement E3).
We performed multiple multivariate analyses of the
whole population studied in order to investigate the
potential factors associated with preferences, types and
procedures of informed consent. Eight multivariate
models are shown in the online data supplement, as well
as submodels of the logistic regression analyzing con-
scious and unconscious patients separately (see online
Table 1 Patients’ and relatives’ characteristics
Patients with relative Patients unaccompanied* Relatives*
n = 125 n = 60 n = 125
Age, years, mean ± SD 63 ± 15 67 ± 14 54 ± 16
Gender, male, n (%) 92 (74) 39 (64) 29 (23)
Educational level n = 123 n = 59 n = 122
Primary studies, n (%) 19 (15) 15 (25) 10 (8)
Secondary studies, n (%) 47 (38) 22 (37) 44 (36)
Higher education, n (%) 57 (46) 22 (37) 68 (56)
Recall of patient’s participation in a study n = 113 n = 59 n = 119
in ICU, n (%) 14 (12) 7 (12) 17 (14)
in hospital, n (%) 23 (20) 15 (25) 28 (24)
Feeling coerced, n (%) 12 (11) 4 (7) 11 (9)
* Definitions: patients unaccompanied = patients had no relative or
relatives who were unavailable or refused to participate in the
study, relatives = patients had an available relative who filled out
the questionnaire
 p \ 0.0001 Single item v2 or t test as required for patients with
relative vs. relatives,  p \ 0.001 Overall multiple v2 for patients
with relative vs. relatives; analysis for patients with relative vs.
patients unaccompanied were nonsignificant
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data supplement E4). Among the five factors identified in
the univariate analysis and included in the final model,
four had a significant impact. Study invasiveness and
feelings of coercion had no impact on preferences for who
should give consent, but they did increase the desire to
have more than one person to provide consent and did
decrease the rate of acceptance for deferred or two-step
consent. Younger individuals were associated with lower
acceptance of two-step consent and increased desire for
signed or witnessed consent. We did not identify any
significant interaction between the independent factors in
any of the multivariate models.
Discussion
The impact of study invasiveness on the preferences of
potential ICU research participants regarding informed
consent has never been investigated. The strengths and
originality of our study are the parallel evaluation of
patients and relatives, and their greater appreciation of
critical illness than the general population.
Our major finding was that study invasiveness had no
impact on patient or relative preferences with regard to
who should give consent. However, it did increase the
desire to have that decision-making responsibility shared
with a second person, especially when the patient was
unconscious. Family and ICU doctors were often
designated in such cases. Likewise, when the patient was
unaccompanied, family doctors were considered the per-
son best qualified to give consent. Study invasiveness
tended to decrease the acceptance rate of deferred or two-
step consent. Procedures for giving consent by signature,
with or without witnesses, were neither influenced by
invasiveness, nor, as our pilot study showed, by the
patient’s state of consciousness [24]. These findings add
to previous data reporting that risks related to a trial do
not change patients’ preferences [23].
The second relevant finding was that up to a third of
patients and relatives would not wish to designate the
patient as the consent-giver, even if he were conscious.
This contrasts strongly with international and national
rules advocating that the patient himself should give
consent. When the patient was unconscious the majority
of respondents chose relatives, but as many as 45 %
preferred other people. This is in line with previous
reports that only 26 % of respondents considered decision
making by relatives to be acceptable in research situations
[27]. These findings raise the important question of
whether it is always judicious to confer the entire burden
of responsibility for giving consent to relatives, or even to
patients, in critical care research. The idea of obtaining
informed consent from more than one person is note-
worthy. This is in line with previous findings suggesting
that relatives would like treating or ICU clinicians to be
responsible for giving consent [22]. Moreover, in our
study, none of the respondents would have turned to a lay
Inclusion 185/462 (40%)
Patients
with relative
125 (68%)
Eligible 462/1375 (34%)
Screened Patients 1375 (100%)Exclusion 913/ 1375 (66%)
Neurological disease              348
Psy./neuro . history                 170
Transfer elsewhere                 130
ICU stay < 24h                       124
Non French speaking               86
Discharged from hospital 39
Deceased 9
< 18 years old 7
No response277/462 (60%)
Questionnaire not returned   169
Not willing to think 39
Great fatigue 25
No interest/Against research   21
Too difficult 12
Already involved in protocols 7
No time/Too stressed               4
Invasive
62
(34%)
Non-
invasive
63
(34%)
Patients 
unaccompanied
No Relatives            25
Refusal                      18
Not available             14
Refusal of the patient  3
60 (32%)
Invasive
30 
(16%)
Non-
invasive
30
(16%)
Relatives
125 (68%)
Invasive
62
(34%)
Non-
invasive
63
(34%)
Fig. 1 Consort flowchart,
ICU: Intensive Care Unit
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person, judge or another hospital physician. The contri-
bution of family or ICU doctors seems comforting to ICU
patients and relatives, more so than from other unknown
professionals. This contrasts with propositions by some
lawyers who would like to see an attorney automatically
attributed to any unconscious patient to be included in a
study [28].
The third surprising finding was that as many as 10 %
of respondents considered informed consent unnecessary
for an invasive study whereas as few as 17 % of
respondents would waive consent for a noninvasive study,
regardless of the patient’s state of consciousness. Taken
together, these results show that people want to be
informed, consulted and allowed to give consent to a
study, whatever its nature. This is in contradiction with
some current rules that would allow a waiving of consent
for observational studies [29]. The suggested requirement
for dual consent in which one person should be the family
or ICU doctor might be a solution regarding the
exceptional and specific circumstances of emergencies
[30, 31]. Our results were also consistent with literature in
which between 50 and 86 % of respondents accepted
deferred consent [22, 32, 33]. This suggests that,
depending on the importance of the study and provided
there has been a scrupulous examination by an IRB or an
Ethics Committee, critical care studies with short thera-
peutic windows may be started without consent [34].
Information about the trial and informed consent to
continue the study should be provided as quickly as
possible.
Unlike recent publications, our study showed close
parallels between patients and relatives with regard to
who should give consent [35].
Younger respondents seemed to have a greater desire
to decide for themselves than older ones, as expressed by
a higher rate of self-designation as consent-giver, and a
decreased willingness to use two-step consent or the
requirement of consent with a signature or a witness. Only
Table 2 Patient and relative subgroup preferences regarding the person who should give consent, according to study invasiveness and the
patient’s state of consciousness
Patient conscious Patient unconscious
Patients
with relative
Patients
unaccompanied
Relatives Patients
with relative
Patients
unaccompanied
Relatives
n = 125
n (%)
n = 60
n (%)
n = 125
n (%)
n = 125
n (%)
n = 60
n (%)
n = 125
n (%)
Invasive study
Total invasive 62 (100) 30 (100) 62 (100) 62 (100) 30 (100) 62 (100)
The person who should consenta    
Patient himself 43 (69) 21 (70) 43 (69) 0 (0) 3 (10) 4 (7)
Relative 8 (13) 2 (7) 8 (13) 42 (68) 6 (20)* 39 (63)
Family doctor 1 (2) 4 (13)* 0 (0) 2 (3) 11 (37)* 1 (2)
ICU doctor 1 (2) 1 (3) 4 (6) 4 (7) 3 (10) 6 (10)
Ethics committee 1 (2) 1 (3) 1 (2) 3 (5) 2 (7) 2 (3)
Informed consent not necessary 7 (10) 1 (3) 6 (10) 6 (8) 2 (7) 6 (10)
No response/otherb 1 (3) 0 (0) 0 (0) 5 (8) 3 (10) 4 (6)
Noninvasive study
Total noninvasive 63 (100) 30 (100) 63 (100) 63 (100) 30 (100) 63 (100)
The person who should consenta   
Patient himself 47 (75) 22 (73) 43 (69) 3 (5) 2 (7) 10 (16)
Relative 5 (7) 1 (3) 9 (14) 39 (61) 14 (48) 37 (59)
Family doctor 1 (2) 0 (0) 2 (3) 1 (2) 4 (13) 3 (5)
ICU doctor 5 (7) 1 (3) 5 (8) 7 (11) 3 (10) 6 (9)
Ethics committee 0 (0) 1 (3) 0 (0) 1 (2) 1 (3) 1 (2)
Informed consent not necessary 3 (5) 4 (13) 4 (6) 4 (6) 5 (17) 3 (5)
No response/otherb 2 (4) 1 (3) 0 (0) 8 (13) 1 (3) 3 (4)
Note: The calculation of the percentages can differ slightly from the
numbers reported on this table because of variation in the number
of responses for each question
ICU: Intensive Care Unit
 p \ 0.001 Overall multiple v2 for conscious vs. unconscious
patient;  p \ 0.02 Single item v2 for conscious vs. unconscious
patient,  p \ 0.05 Overall multiple v2 for Invasive vs. Noninva-
sive study,  p \ 0.05 Single item v2 for Invasive vs. Noninvasive
study, * p \ 0.05 Single item v2 for patients with relative vs.
patients unaccompanied
a Agreement between patients with relative and relatives expressed
as Kappa (%) were of 0.61 (81) for the designation of the person
who should give consent in the case of a conscious patient for the
invasive study, and 0.26 (65) for the noninvasive study, while in the
case of an unconscious patient, the percentage was of 0.35 (66) for
the invasive study, and 0.42 (65) for the noninvasive study
b lay representative, judge or hospital doctor outside the ICU
1286
a small proportion of participants reported feeling
coerced. However, this feeling increased the desire to
have more than one person to give consent and decreased
the rate of acceptance of deferred or two-step consent.
These results should remind researchers that their attitude
during the procedure of seeking consent can have an
impact on inclusion rates [15].
Overall, a high rate of patients and relatives did desire
a signature and the presence of a witness for informed
consent, independently of study invasiveness. Our results
confirm that seeking out relatives to give consent when
the patient is unconscious is the right thing to do, as is
currently the practice for ICU research in most countries.
Our study presents some limitations. Firstly, the 40 %
patient response rate is low. Nonetheless, this was an
increase on our pilot study. Such participation rates are
not rare in ICU research [20, 23, 24, 36, 37], especially
for complex questionnaires on vignettes. This is
undoubtedly due to patients’ considerable residual fatigue
and other impairments after recent ICU stays (Fig. 1). The
68 % response rate among relatives is acceptable. Sec-
ondly, we cannot exclude the bias that respondents may
have been favorably predisposed towards research [38].
However, the equal participants’ distribution in the two
study groups (invasive and noninvasive) and the fact that
the patient characteristics were similar to usual ICU
populations, suggests that our data is representative.
Thirdly, the study design precludes direct comparisons of
how any individual would feel about both the invasive
and the noninvasive study. We considered it too confus-
ing to ask the same participant to compare the two study
types in conscious and unconscious patients. As for ran-
domized controlled trials we assume that the groups are
similar at baseline. Also, our vignettes may not represent
the most frequent research situations in critical care.
Fourthly, the results come from a single center in Swit-
zerland and might not be applicable to other centers or
countries. Cultural differences might play a role. How-
ever, our findings are in accordance with previous US or
Canadian publications [22, 23]. This might enhance the
credibility of our study’s original findings.
Conclusion
Our study provides helpful information on informed
consent procedures. The surprising finding was that study
invasiveness had no impact on the choice of who should
give consent. Invasiveness increased the desire that con-
sent be given by more than one person and decreased the
acceptance rate of deferred or two-step consent. Our
results confirm that current research rules comply with
people’s wishes, i.e. that consent be given by themselves
when patients are conscious and by the relative when
unconscious. When patients are unaccompanied, they
prefer that someone they know is asked to give consent.
The original idea to have a second person available—for
example, family or ICU doctors—who would give con-
sent together with the patient or the relative could be
helpful and might also reduce feelings of coercion
expressed by some participants. Further studies should
Table 3 Patient and relative subgroup preference for more than one person to give consent and preferences about the type of informed
consent, depending on study invasiveness and the patient’s state of consciousness
Patient conscious Patient unconscious
Patients
with
relative
Patients
unaccompanied
Relatives Agreement
patients with
relative–
relative
j (%)
Patients
with
relative
Patients
unaccompanied
Relatives Agreement
patients with
relative–
relative
j (%)
n = 125
n (%)
n = 60
n (%)
n = 125
n (%)
n = 125
n (%)
n = 60
n (%)
n = 125
n (%)
Invasive
Total invasive 62 (100) 30 (100) 62 (100) 62 (100) 30 (100) 62 (100)
More than one person
should give consent
28 (45) 8 (26) 36 (58) 0.46 (73) 32 (55) 11 (38) 37 (60) 0.49 (73)
Deferred consent 33 (60) 15 (50) 36 (59) 0.44 (68) 33 (58) 16 (53) 28 (46) 0.47 (67)
Consent in two steps 39 (66) 22 (73) 43 (69) 0.41 (71) 39 (68) 19 (63) 39 (64) 0.46 (71)
Noninvasive
Total noninvasive 63 (100) 30 (100) 63 (100) 63 (100) 30 (100) 63 (100)
More than one person
should give consent
19 (30) 9 (30) 20 (32) 0.52 (79) 20 (36) 15 (50) 23 (37) 0.41 (68)
Deferred consent 41 (66) 22 (76) 43 (68) 0.23 (62) 37 (59) 24 (86) 33 (52) 0.30 (59)
Consent in two steps 45 (75) 25 (86) 44 (70) 0.36 (71) 44 (70) 25 (86) 41 (64) 0.23 (63)
Note: The calculation of the percentages can differ slightly from the numbers reported in this table because of variation in the number of
responses for each question
 p \ 0.05 Single item v2 for Invasive vs. Noninvasive study
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test such new possibilities for informed consent in ICU
research.
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